Mersana Therapeutics所有資訊

Mersana Therapeutics | SC 13G：超過5%持股股東披露文件-Nextech Crossover I SCSp(5.1%),Nextech Crossover I GP S.à r.l.(5.1%)等

05/17 08:27 (美東)

Mersana Therapeutics | 4：持股變動聲明-董事 Alleva Lawrence M

04/03 20:19 (美東)

Mersana Therapeutics | 4/A：持股變動聲明(修正)-高管 Mandelia Ashish

02/16 16:33 (美東)

Mersana Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(9.4%),VHCP Co-Investment Holdings III, LLC(9.4%)等

02/14 20:58 (美東)

Mersana Therapeutics | SC 13G：超過5%持股股東披露文件-SilverArc Capital Management, LLC(5.3%),Devesh Gandhi(5.3%)

02/14 20:48 (美東)

Mersana Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-OrbiMed Capital LLC(0.0%),OrbiMed Advisors LLC(0.0%)

02/14 18:58 (美東)

Mersana Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)

02/14 09:22 (美東)

Mersana Therapeutics | SC 13G：超過5%持股股東披露文件-Balyasny Asset Management L.P.(8.04%),BAM GP LLC(8.04%)等

02/14 07:26 (美東)

Mersana Therapeutics | SC 13G：超過5%持股股東披露文件-The Vanguard Group(5.17%)

02/13 22:44 (美東)

Mersana Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(6.5%)

01/29 15:31 (美東)

Mersana Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-STATE STREET CORPORATION(1.93%)

01/22 00:00 (美東)

Mersana Therapeutics | 4：持股變動聲明-董事 Protopapas Anna

01/17 00:00 (美東)

Mersana Therapeutics | 4：持股變動聲明-高管 Carvajal Alejandra

01/17 00:00 (美東)

Mersana Therapeutics | 4：持股變動聲明-高管 Huber Martin H. Jr.

01/17 00:00 (美東)

Mersana Therapeutics | 4：持股變動聲明-高管 Lowinger Timothy B

01/17 00:00 (美東)

Mersana Therapeutics | 4：持股變動聲明-高管 Mandelia Ashish

01/17 00:00 (美東)

Mersana Therapeutics | 4：持股變動聲明-高管 MISRA TUSHAR

01/17 00:00 (美東)

Mersana Therapeutics | 4：持股變動聲明-高管 DeSchuytner Brian

01/17 00:00 (美東)

Mersana Therapeutics | 4：持股變動聲明-高管 Bala Mohan

01/17 00:00 (美東)

Mersana Therapeutics | 4：持股變動聲明-董事 Hege Kristen

01/04 00:00 (美東)